CAS No. 153533-45-0

2-Butenoic acid,4-[[4-[(5,7-diethyl-2-oxo-1,6-naphthyridin-1(2H)-yl)methyl]phenyl]amino]-4-oxo-3-phenyl-

Catalog No.	1738728
Name	2-Butenoic acid,4-[[4-[(5,7-diethyl-2-oxo-1,6-naphthyridin-1(2H)-yl)methyl]phenyl]amino]-4-oxo-3-phenyl-
CAS	153533-45-0
Formula	C29H27N3O4

Request a Quote SDS

About 2-Butenoic acid,4-[[4-[(5,7-diethyl-2-oxo-1,6-naphthyridin-1(2H)-yl)methyl]phenyl]amino]-4-oxo-3-phenyl-

2-Butenoic acid,4-[[4-[(5,7-diethyl-2-oxo-1,6-naphthyridin-1(2H)-yl)methyl]phenyl]amino]-4-oxo-3-phenyl- is a chemical compound registered under CAS number 153533-45-0, with the molecular formula C29H27N3O4 and a molecular weight of about 481.55 g/mol. ProvideChemical supplies 2-Butenoic acid,4-[[4-[(5,7-diethyl-2-oxo-1,6-naphthyridin-1(2H)-yl)methyl]phenyl]amino]-4-oxo-3-phenyl- for laboratory research and bulk production; product code 1738728. Send an inquiry for purity, packaging, price and lead time.

CAS Number: 153533-45-0
Molecular Formula: C29H27N3O4
Molecular Weight: 481.55 g/mol

Related Keywords

amino

diethyl

butenoic

naphthyridin

1,6-Naphthyridin-n

Benzenemethanol,a-[1-[[(3-hydroxyphenyl)methyl]amino]-1-methylethyl]-

2-Pyrimidinamine,4-butyl-N-(2-methyl-5-nitrophenyl)-6-(4-methylphenyl)-

Pyridinium,3-[4-acetyl-5-(1,3-benzodioxol-5-yl)-4,5-dihydro-1,3,4-oxadiazol-2-yl]-1-methyl-, iodide

Methanone,[1-[2-hydroxy-3-(1-pyrrolidinyl)propyl]-2-methyl-1H-indol-3-yl](4-methoxyphenyl)-, monomethanesulfonate (salt)

Quinazoline, 2-(2,3-dichlorophenyl)-1,2,3,4-tetrahydro-

[1,4'-Bipiperidin]-4-amine,N-[1-[(3-chlorophenyl)sulfonyl]-4-piperidinyl]-N-(cyclopropylmethyl)-1'-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4'-methyl-

501445-52-9

1-Piperidinecarboxylic acid,3-[[1'-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4'-methyl[1,4'-bipiperidin]-4-yl]amino]-, 1,1-dimethylethyl ester

3-A-(O-TERT-BUTYLDIPHENYLMETHOXY)-9-METHYL-9-AZABICYCLO[3.3.1]NONANE

3-methylpyrido[1,2-a]pyrazin-2-ium 2-oxide;bromide

Silane, 2-furanyldimethyl(2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl)-

Hydrazinecarboxamide,N,N'-(methylenedi-4,1-phenylene)bis[2,2-dimethyl-, compd. withpyridine (1:1)

Phosphonium, [3-(4-cyano-2-nitrophenyl)-2-propenyl]triphenyl-, bromide

104291-60-3

(s)-N-Boc-2-cyanopiperidine

N-[4-Oxo-4-(4-pyridinylamino)butyl]carbamic acid tert-butyl ester

3-Thiophenamine, 5-ethyl-2-(1H-pyrazol-1-yl)-

[1,4'-Bipiperidin]-4-amine,1'-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4'-methyl-N-phenyl-N-(2-phenylethyl)-

SODIUM NITRATE:

Strontium-87(2+)

66650-08-6

Benzoic acid, 4-(2-methyl-6-phenyl-4-pyrimidinyl)-, methyl ester

[1,4'-Bipiperidin]-4-amine,N-[4-bromo-3-(trifluoromethyl)phenyl]-N-(phenylmethyl)-1'-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4'-methyl-

3-A-(P-METHYLDIPHENYLMETHOXY)-9-METHYL-9-AZABICYCLO[3.3.1]NONANE

2-Cyclohexen-1-one, 6-(acetyloxy)-3-ethoxy-5-methyl-6-phenyl-

4-amino-n-(6-methoxypyrimidin-4-yl)benzenesulfonamide;hydrate

1-Piperidinecarboxamide,4-[[4-(2-aminoethyl)phenyl]amino]-N-[(3-methoxyphenyl)methyl]-

392635-63-1

Thieno[2,3-d]pyrimidine-6-carboxylic acid,5-amino-2-(2-furanyl)-4-(3-nitrophenyl)-, ethyl ester

Hydrazinecarboxamide,N,N'-(methylenedi-4,1-phenylene)bis[2,2-dimethyl-, compd. withtetrahydrofuran (1:2)

5-Pyrimidinecarbonitrile,2-(2-furanyl)-1,4-dihydro-6-(3-nitrophenyl)-4-oxo-

2-Oxazolidinethione,3-[(2R,3R)-3-hydroxy-1-oxo-2-(2-propenyloxy)octyl]-4-(phenylmethyl)-,(4S)-

[1,4'-Bipiperidin]-4-amine,N-(3-cyanophenyl)-N-(phenylmethyl)-1'-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4'-methyl-

Benzamide,3-[[1'-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4'-methyl[1,4'-bipiperidin]-4-yl](phenylmethyl)amino]-N-hydroxy-

501446-16-8

1,3-Octanediol, 2-(2-propenyloxy)-, (2S,3R)-

Ethanone, 1-[5-(4-methyl-1H-imidazol-1-yl)-4-nitro-2-thienyl]-

2H-Isophosphindole, 4,5,6,7-tetrahydro-

1-Piperidinecarboxylic acid,4-[phenyl[6-(trifluoromethyl)-3-pyridinyl]amino]-, 1,1-dimethylethyl ester

1H-Imidazole, 4,5-dichloro-1-(2-nitro-3-thienyl)-

(5Z)-11H-dibenzo[2,1-a:1',2'-f][8]annulen-12-one